Taiwan Television Enterprise Co., Ltd. logo

Taiwan Television Enterprise Co., Ltd. (8329)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
10. 75
+0.35
+3.3654%
NT$
- Market Cap
- P/E Ratio
- Div Yield
28,442 Volume
- Eps
NT$ 10.4
Previous Close
Add Transaction
Day Range
10.45 10.8
Year Range
9.59 12.45
Want to track 8329 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

8329 closed today higher at NT$10.75, an increase of 3.3654% from yesterday's close, completing a monthly increase of 2.8708% or NT$0.3. Over the past 12 months, 8329 stock gained 1.4151%.
8329 pays dividends to its shareholders, with the most recent payment made on Sep 25, 2025. The next announced payment will be in In 1 month on Sep 24, 2026 for a total of NT$0.75.
The last earnings report, released on Aug 21, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

8329 Chart

Taiwan Television Enterprise Co., Ltd. (8329) FAQ

What is the stock price today?

The current price is NT$10.75.

On which exchange is it traded?

Taiwan Television Enterprise Co., Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 8329.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Taiwan Television Enterprise Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Taiwan Television Enterprise Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
TWSE Exchange
TW0008329004 ISIN
Hong Kong Country
1,471 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Shenzhen Neptunus Interlong Bio-technique Company Limited is a dynamic enterprise that focuses on the research, development, production, and sale of medicines and medical devices across the People's Republic of China. With its roots deeply embedded in Quarry Bay, Hong Kong, it operates as a significant subsidiary under the auspices of Shenzhen Neptunus Bio-engineering Company Limited. The company prides itself on its comprehensive portfolio that addresses various therapeutic needs while simultaneously engaging in the commerce and distribution of healthcare food products. Furthermore, it undertakes endeavors in the realm of biological technology research and development, cementing its position as a notable entity in the biomedical sector.

Products and Services

The company’s offerings can be broadly categorized into two main areas: medicinal products and auxiliary services, each tailored to cater to comprehensive healthcare needs. Below is a breakdown of its primary products and services:

  • Medicines: Shenzhen Neptunus Interlong Bio-technique Company Limited specializes in a wide array of medical treatments targeting critical therapeutic areas such as:
    • Oncology: Developing groundbreaking cancer treatments designed to tackle various forms of the disease with the aim of improving patient survival rates and quality of life.
    • Cardiovascular system: Offering medications that manage heart-related conditions effectively, ensuring better cardiovascular health among patients.
    • Respiratory system: Producing treatments for diseases affecting the lungs and airways, contributing to improved respiratory functions.
    • Digestive system: Providing solutions for digestive disorders, aiding in the overall digestive health and wellness.
    • Mental disorders: Innovating in the realm of mental health, the company boasts a range of medications aimed at combating various mental illnesses, thereby facilitating better mental health outcomes.
  • Medical Devices: The company's dedication extends beyond pharmaceuticals to encompass the development and production of state-of-the-art medical devices. These contributions are pivotal in diagnosing, preventing, and treating diseases, thereby enhancing the overall healthcare landscape.
  • Healthcare Food Products: Acknowledging the intrinsic link between nutrition and health, Shenzhen Neptunus Interlong Bio-technique Company Limited also delves into the healthcare food sector. It aspires to offer food products that not only nourish but also bolster health and well-being among consumers.
  • Biological Technology Research and Development: The company is profoundly invested in the research and development of biological technologies. This venture underscores its commitment to innovating and pioneering advancements in biotechnology, aiming to pave new avenues in medical science and healthcare solutions.

Contact Information

Address: One Taikoo Place
Phone: -